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Abstract
Cocaine methiodide (CM), a charged cocaine analog, cannot pass the blood brain barrier. It has been assumed the effects of
systemic CM represent cocaine actions in peripheral tissues. However, the IC50 values of CM have not been clearly
determined for the major cocaine targets: dopamine, norepinephrine, and serotonin transporters, and sodium channels.
Using cells transfected with individual transporters from mice and synaptosomes from mouse striatum tissues, we observed
that the inhibition IC50 values for monoamine uptake by CM were 31-fold to 184-fold higher compared to cocaine at each of
the transporters. In dorsal root ganglion neurons, cocaine inhibited sodium channels with an apparent IC50 of 75 mM, while
CM showed no observable effect at concentrations up to 3 mM. These results indicate that an equal dose of CM will not
produce an equivalent peripheral effect of cocaine.
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Introduction
Cocaine produces complex behavioral and physiological effects
including: addiction and locomotor stimulation, cardiac arrhyth-
mias, and hormonal changes [1,2]. The high affinity targets of
cocaine include the dopamine (DA) transporters (DAT), norepi-
nephrine (NE) transporters (NET), and serotonin transporters
(SERT) [3]. Cocaine inhibits these transporters with similar
potencies at micromolar or submicromolar levels [4].
Cocaine produces effects in the central nervous system (CNS)
primarily by inhibiting three monoamine transporters, DAT, NET
and SERT [3]. These transporters clear neurotransmitters from
neural synapses and surrounding areas through monoamine
reuptake [1]. Cocaine inhibition of these reuptake processes
results in prolonged monoamine elevation in brain regions that
promote reward and addiction [1]. Cocaine also blocks sodium
channels but with lower potencies (50 mM or higher) [5]. These
cocaine targets are expressed in both the CNS and the peripheral
systems [6,7].
Many chemical analogs of cocaine have previously been
synthesized [8,9]. Cocaine methiodide (CM) is a chemical analog
of cocaine with a stable positive charge at physiological pH. The
positive charge of CM prevents a systemic administered dose from
crossing the blood brain barrier [10]. Therefore, CM should only
inhibit the functions of cocaine target proteins in peripheral
tissues.
It has been observed that the toxic effects of systemic CM,
measured in vivo by median lethal doses (LD50), are similar to that
of cocaine [11,12], leading to the presumption that the potencies
of CM and cocaine for peripheral targets might be similar.
Accordingly, several investigations examined the effects of systemic
CM with the presumption that the results represented cocaine
interactions with peripheral cocaine targets at similar doses
[10,13].
However, some studies have shown that CM and cocaine may
have different potencies at cocaine targets. CM was shown to be
less potent than cocaine at inhibiting NE uptake in aortic tissues
dissected from guinea pigs and rats [14]. CM was found to be less
potent than cocaine at inhibiting the binding of mazindol [15] to
rat striatal tissue preparations. In addition, in vivo data showed
that CM via intracranial delivery did not produce comparable
results to cocaine in rat self-administration tests [16].
While these prior CM studies are relevant to compare the effects
of CM to cocaine, they were performed in tissue preparations that
contain multiple cocaine targets with varying expression levels.
Accordingly, the concentration-responses for these two drugs have
not been clearly determined for each major target of cocaine
(DAT, NET, SERT or sodium channel subtypes). Therefore, we
aimed to determine the potency of CM and cocaine at inhibiting
major cocaine target proteins and thus testing the hypothesis that
CM is similarly potent as cocaine and would produce similar
effects in peripheral tissues.
Results
Previous pharmacological studies of CM on CNS proteins
utilized dissected tissues or tissue homogenates. Depending on the
source, these homogenized tissue samples have variable expres-
sions of multiple cocaine target proteins. In addition, monoamine
transporters share substrates and high affinity inhibitor com-
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to the transporters. To study the effect of CM on individual
transporter cocaine targets, we used cells transiently transfected
with individual transporter cDNAs. Because mouse models were
used in recent publications on the study of CM [7,17,18] we chose
the three mouse monoamine transporter cDNAs for transfection.
Figures 1A–C show the concentration-response curves for CM and
cocaine inhibition of monoamine uptake by each of the three
transporters. Each experiment was run in triplicate and the
experiments were repeated 3 times with similar results. The
average IC50 values for cocaine and CM respectively were: for
mDAT, 0.4560.11 mM and 83.262.1 mM, a 184 fold increase;
for mNET, 0.6760.09 mM and 20.963.1 mM, a 31 fold
difference; and for mSERT, 0.6860.39 mM and 84.364.8 mM,
a 123 fold difference. Student’s paired t-tests showed that the IC50
values of CM and cocaine were significantly different for each of
the 3 transporters (p,0.001 for all three comparisons). These
results are summarized in Table 1.
In addition to the experiments with cultured cells expressing the
transporters, we also examined CM and cocaine inhibition of
Figure 1. Concentration-response curves for cocaine and cocaine methiodide. Dopamine uptake by mouse DAT (A), norepinephrine
uptake by mouse NET (B), and serotonin uptake by mouse SERT (C) into transfected cells were measured in the presence of increasing concentrations
of cocaine or cocaine methiodide. The Na
+ channel currents in isolated mouse DRG neurons were recorded by whole-cell patch clamping (D). The
data are presented as the percent of the pre-drug activity. Dopamine uptake by striatal synaptosomes were measured in the presence of increasing
concentrations of cocaine or cocaine methiodide (E). For A, B, C, and E, each data point represents the average of triplicate measurements 6 standard
error of means and the experiments were repeated three times with similar results. For D, each data point was obtained from four cells.
doi:10.1371/journal.pone.0007578.g001
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prepared from the striatum of healthy adult C57B6 mice. Standard
uptake assays were performed to measure CM and cocaine
inhibition. The results are shown in Figure 1E (n=3, p,0.001).
The average IC50 values for cocaine and CM were 0.3560.11 mM
and 11.765.1 mM respectively, a difference of 33 fold.
Cocaine is well known to block the function of sodium channels
[19]. However, the effect of CM on sodium channels has not been
reported. Since CM is primarily used to identify cocaine effects in
the periphery, where sodium channels are potential targets, we
sought to determine whether CM and cocaine had similar
potencies on sodium channels in peripheral nerves. DRG neurons
express several different fast and slow responding sodium channel
subtypes, including NaV1.1, NaV1.6, NaV1.7, NaV1.8, and NaV1.9
[20]. DRG neurons provide convenient samples to examine the
inhibitory effect of cocaine and CM on multiple sodium channels.
Whole-cell recordings were performed using mouse DRG
neurons. Sodium currents were elicited by depolarization to
desired test potentials from the holding of 270 mV in the absence
and presence of cocaine or CM as described in Materials and
Methods. Figure 2 shows representative inward current traces
recorded from DRG neurons, before and during cocaine
application, as well as after cocaine washout. As shown in
Figure 2A–2D, cocaine dose dependently inhibited the rising
phase of the inward current. Peak currents obtained from 10
voltage pulses were averaged for each drug concentration and
normalized to the control value before the drug application. The
concentration-response curve is shown in Figure 1D for compar-
ison with the monoamine transporters. IC50 values were
determined for cocaine inhibition of the sodium channels in
mouse DRG neurons with an average value of 84.865.9 mM
(n=4) (Table 1). This data is consistent with previous work that
the potency of cocaine in inhibiting sodium channels is roughly
100 fold lower than those for the monoamine transporters [5].
However, when CM was applied to isolated DRG neurons, little
effect was observed on the sodium channel currents. Even at
3 mM of CM, the highest concentration tested, very little
inhibition was observed in peak inward current (Figure 2E, n=4
Table 1. Cocaine and cocaine methiodide IC50 values for the
inhibition of monoamine transporters and DRG neuron Na
+
channels.
IC50 [mM]
a Cocaine
Cocaine
Methiodide ratio p value
b
Striatal synaptosomes 0.3560.11 11.565.1 33 ,0.001
mDAT 0.4560.11 83.262.1 184 ,0.001
mNET 0.6760.09 20.963.1 31 ,0.001
mSERT 0.6860.39 84.364.8 123 ,0.001
DRG Na+ Channels 84.865.9 not measured --- ---
aThe IC50 values are mean 6 standard error of means calculated from 3
independent experiments.
bSignificance was determined by Student’s paired t-test.
doi:10.1371/journal.pone.0007578.t001
Figure 2. Effects of cocaine and cocaine methiodide on sodium channels in DRG neurons. Isolated mouse DRG neurons were voltage-
clamped in the whole-cell mode, held at 270 mV and sodium channels were activated by 10 consecutive pulse stimulations (10 Hz, 50 ms duration,
depolarized from 270 mV to 225 mV). Representative currents recorded before drug addition (before drug), during the drug (during drug) and after
drug washout (after drug) are overlaid for 30 (A), 100 (B), 300 (C) and 1,000 mM (D) cocaine as well as 3 mM cocaine methiodide (E).
doi:10.1371/journal.pone.0007578.g002
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value. While concentrations higher than 3 mM may inhibit
sodium channels, doses equivalent to such concentrations would
be much higher than the LD50 and thus not likely to be used in
animals. Therefore, we limited our experiments to 3 mM.
Figure 1D shows the effect of CM on sodium channel currents
from 3 mM to 3 mM. To rule out that the ECS used in the DRG
experiments may interfere with CM actions, we performed
transport assays with HeLa cells using the ECS as for the DRG
experiments. The results were not different from the experiments
using the PBS/Ca/Mg buffer (data not shown).
Discussion
Since CM cannot pass across the blood brain barrier, it had
been used in studies attempting to separate the CNS effects from
the peripheral effects of cocaine. The effective concentrations for
CM and cocaine used in these studies were similar based on the
assumption that the IC50 values for CM and cocaine are similar
for major target proteins. The data presented in this paper shows
very substantial differences between potencies of cocaine and CM
in inhibition of major cocaine target proteins.
We found that the individual IC50 values for CM are 184-fold,
31-fold, and 123-fold higher than those for cocaine at DAT, NET,
and SERT respectively. We also found that cocaine inhibits the
sodium channels in DRG neurons with an apparent IC50 of
85 mM, about 100-fold higher than those for the monoamine
transporters. The sodium channel inhibition data shown in
Figure 1D fit well with a single IC50 value, suggesting that the
individual CM IC50 values for each sodium channel subtypes are
similar. In contrast, doses of CM up to 3 mM have little
observable effect on sodium channels expressed in DRG neurons.
It remains to be determined whether the sodium channel subtypes
that are not expressed in DRG neurons can be inhibited by CM
and whether those channels have similar sensitivities to CM and
cocaine.
Cocaine has been referred as a ‘‘dirty drug’’ due to its multiple
sites of action within the CNS and peripheral tissues [21].
Separating the cocaine actions in the CNS from peripheral tissue
contributions can be beneficial in understanding complex cocaine
effects. Our data show that CM and cocaine have very different
potencies on the major cocaine targets, and therefore, equimolar
systemic doses of CM do not produce equivalent inhibition of
major cocaine targets.
Our data with DRG neurons raises interesting questions about
how systemic CM produces its effects which was hypothesized to
result primarily from CM inhibition of peripheral Na
+ channels
[7]. Our CM electrophysiology data excludes the five sodium
channel subtypes commonly expressed in DRG neurons from
mediating this peripheral effect. The effects of CM at other sodium
channel subtypes, not expressed in DRG neurons, remain
unknown. Indeed, recent reports show that the peripheral
glutamate system is involved in rapid CNS effects observed with
intravenous administration of cocaine and CM [18]. However, it is
clear from our data that equivalent doses of CM should not be
used to examine the effects of cocaine interaction with its
peripheral targets.
The use of CM to measure the effects of peripheral cocaine
stems from previous reports of similar LD50 values for cocaine and
CM [11,12], which suggests the two drugs have similar potencies
at the targets that mediate the lethal effects. In stark contrast, we
observed remarkable differences between the potencies of CM and
cocaine. Our results suggest that the lethal toxic effects of cocaine
and CM are not likely through the inhibition of the monoamine
transporters or subtypes of sodium channels expressed in DRG
neurons. Other target proteins might be involved. One study
shows that cocaine is a low affinity antagonist at a7-nicotinic
acetylcholine receptor (nAChR) while CM is a high affinity agonist
of the receptor [22]. Another study indicates that CM produces
weaker effect than cocaine in a conditioned taste aversion test [23].
It has also been proposed that the toxic effects of cocaine emanate
from an unknown site in the peripheral tissue [6]. Future
experiments are needed to identify other CM target proteins
and to understand why CM and cocaine have similar LD50 in
animals.
The data presented here show that CM is much less potent than
cocaine at inhibiting monoamine transporters and thus similar
doses of CM will not inhibit the transporters to the same extent.
We also observed that a very high dose of CM does not inhibit
sodium channels expressed in DRG neurons. Therefore, systemic
CM effects are not good measurements of cocaine actions through
its peripheral targets.
Materials and Methods
Substrate reuptake into transiently transfected cells
Plasmid DNA containing mDAT, mNET, and mSERT were
cloned into bluescript vector with a T7 promoter as described
[24,25]. HeLa cells (American Type Culture Collection, Rockville,
MD) were grown in 96-well plates, infected with recombinant
vTF-7 vaccinia virus, carrying the T7 polymerase gene, and
transiently transfected with the plasmids bearing cDNAs
using Lipofectin (Invitrogen Corp., Carlsbad, CA) as described
previously [24].
About 20–24 h after transfection, HeLa cells were assayed for
substrate uptake in 96-well plates at room temperature using the
PBS/Ca/Mg buffer (phosphate buffered saline solution containing
1 mM MgCl2, 0.1 mM CaCl2, and 50((M L-ascorbic acid). For
determination of IC50 values, cells were co-incubated in the PBS/
Ca/Mg buffer with added 60 nM [3H]-labeled monoamine
substrates and increasing concentrations of an inhibitor (e.g.,
cocaine or CM). Uptakes were terminated by two successive
washes with PBS/Ca/Mg. Amounts of [3H]-labeled substrates
accumulated in the cells were quantitated by liquid-scintillation
counting. All experiments were performed in triplicates. Cells
transfected with vehicle were used as controls and radioactivity
associated with these cells were considered the background. This
background was subtracted from the total scintillation counts of
the wells.
Dopamine reuptake into synaptosomes
All animal work was conducted in adherence to OSU IACUC
approved protocols and guidelines for animal welfare. C57B6 mice
(aged 6–8 weeks) were decapitated and striatum were dissected
from both sides of the brain and stored on ice. The tissues were
placed in ice-cold Krebs’-Ringer’s solution buffer (KRB) (in mM:
125 NaCl, 1.2 KCl, 1.2 MgSO4, 1.2 CaCl2, 22 NaHCO3, 1
NaH2PO4, and 10 glucose, adjusted to pH 7.4) with an additional
0.32 M sucrose. Tissue samples were homogenized by using a
glass homogenizing tube and with a Teflon-coated pestle. The
samples were centrifuged for 10 min at 1,000xg. Supernatant was
collected and the debris pellet was discarded. Supernatant was
centrifuged for 15 min at 16,000x g. The resulting pellet contained
synaptosomes, and was resuspended in KRB supplemented with
pargyline (50((M) and ascorbic acid (100 mM). Synaptosomes were
assayed for substrate uptake at room temperature using a PBS/
Ca/Mg buffer (phosphate buffered saline solution containing
1 mM MgCl2, 0.1 mM CaCl2, and 50 mM L-ascorbic acid). For
Potency of Cocaine Methiodide
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the PBS/Ca/Mg buffer with added 60 nM [
3H]-labeled dopa-
mine, 100 mM desipramine (NET-selective inhibitor) and increas-
ing concentrations of an inhibitor (e.g., cocaine or CM). Uptakes
were terminated by two successive washes with PBS/Ca/Mg and
the vesicles containing the transported substrates were collected
through 96-well microfilter plates (Millipore, Irvine, CA). Amounts
of [
3H]-labeled dopamine accumulated were quantitated by
liquid-scintillation counting. All experiments were performed in
triplicates. Synaptosomes with the highest dose of inhibitor were
used as background controls and radioactivity associated with
these wells were subtracted from the total scintillation counts of all
wells.
Whole-cell voltage clamp recording of sodium channel
currents in dorsal root ganglion neurons
Dorsal root ganglion (DRG) neurons (T1–T10) from adult male
C57B6 mice (aged 6–8 weeks) were isolated as per Malin et al. [26]
Briefly, ganglia were dissected under stereo microscope and
washed in Ca
2+/Mg
2+-free Hank’s Buffered Salt Solution (HBSS).
DRGs were digested enzymatically, first with papain and then
collagenase II and dispase II, each for 10 min at 37uC. Digested
DRGs were then triturated in culture media (F-12 supplemented
with 10% FBS and 5 mg/ml penicillin/streptomycin) by a fire-
polished Pasteur pipette until solution becomes cloudy. Isolated
DRG neurons were plated on poly-ornithine coated glass cover
slips and maintained in a 37uC, 5% CO2 incubator. Individual
DRG neurons were recorded after overnight culture.
Plated coverslips were centered in a perfusion chamber filled
with extracellular solution (ECS) containing (in mM): 140 NaCl, 5
KCl, 2 CaCl2, 1 MgCl2, 10 glucose, 10 HEPES, pH 7.4. Cocaine
and CM were dissolved in ECS and delivered via a pressure-
driven perfusion system (SmartSquirt 8, AutoMate Scientific) with
the tip positioned so the DRG neuron being recorded was fully
within the direct stream of perfusate. Recording pipettes were
pulled from micropipette glass (World Precision Instruments,
Sarasota FL) to 2–4 MV when filled with an intracellular solution
containing (in mM): 140 CsCl2, 1 CaCl2, 2 MgCl2, 11 EGTA, 10
HEPES, 2 Mg2ATP, pH 7.2). Whole-cell recordings were made
using an EPC10 amplifier and the PatchMaster 2.2.0 software
(both from HEKA Electronik, Germany). As soon as the whole-
cell configuration was established, fast and slow capacitances were
cancelled and the holding potential (Vh) was set to -70 mV. A step
protocol (16 steps from 270 mV to 10 mV with 5 mV increment
for each step) was applied to determine the testing voltage (Vt) that
generated the maximal inward current in the following experi-
ment. Sodium channels were activated by a 10 consecutive pulse
stimulation (10 Hz, 50 ms duration, depolarized from Vh to Vt).
Data were filtered at 3 kHz and digitized at 20 kHz. All recordings
were made at room temperature (22–24uC). Only one cell per
cover slip was recorded to avoid possible drug contamination of
other cells. Representative current traces were redrawn in Origin
8.0 SR1 (Northampton, MA).
A range of drug concentrations, starting from low to high, were
tested for each DRG neuron. The sodium channel currents were
recorded 30 s before the drug application, during the 30 s drug
application, and 30–60 s after drug washout by perfusion with
ECS. For each set of tests, current amplitude was measured by
subtracting the baseline value from the peak current. The current
amplitude during the drug was normalized to that before the drug
application, and the normalized values were used to plot the dose-
response curve. The currents measured after the drug washout
were used to confirm the complete recovery before testing the next
drug concentration.
Data analysis
The IC50 values were determined by nonlinear regression
analyses of experimental data using GraphPad Prism 3.0 (San
Diego, CA). IC50 values presented are averages 6 standard error
of means (SEM) calculated from 3 independent uptake experi-
ments or recordings of 4 different DRG neurons. Statistical
analyses for the difference between the IC50 values of the two
drugs were performed by Student’s paired t-test using SPSS 17.0
(Chicago, IL).
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